Business Briefing: F.D.A. Approves Eli Lilly Drug for Advanced Lung Cancer

The agency approved Portrazza, in combination with two forms of chemotherapy, to treat advanced squamous nonsmall cell lung cancer, the most common type.











from NYT > Health http://ift.tt/21f5Vko
via health&fitness